CMA Bids To Reverse Nixed £100M Fine In Drug-Pricing Case
The U.K.'s competition watchdog on Wednesday sought to overturn a ruling that upended more than £100 million ($128.4 million) in fines against drug companies for allegedly reaching agreements related to hydrocortisone...To view the full article, register now.
Already a subscriber? Click here to view full article